Genomic News and Research

RSS

SARS siRNA studied further to help many respiratory diseases including lung cancer

Intradigm Corporation, has announced achievement of prophylactic and therapeutic effects of siRNA (small interfering RNA) inhibitors of SARS-CoV in non-human primate cells. The results are published in the June 2004 issue of Antiviral Therapy (International Medical Press).

15 Jun 2004

Significance of the discovery of anthrax toxin genes in a naturally occurring microbe other than Bacillus anthracis

Dr. Fraser discusses, for the first time, the significance of the discovery of anthrax toxin genes in a naturally occurring microbe other than Bacillus anthracis, the bacterium that causes anthrax.

14 Jun 2004

Biologist has identified gene patterns that characterize a biologically distinct subtype of estrogen receptor negative breast tumor

University of North Carolina molecular biologist Charles Perou has identified the pattern of genes that characterize a biologically distinct subtype of estrogen receptor negative breast tumor.

14 Jun 2004

Mammograms, wider access, better technologies needed

Mammography has helped lower the death rate from breast cancer, but a new report by the Institute of Medicine says much could be done to improve breast cancer screening and save even more lives.

12 Jun 2004

GenoMed launches campaign to improve patient outcomes for diabetes, high blood pressure and emphysema

GenoMed, Inc., a Next Generation DM™ (Disease Management) company that uses its expertise in genomics to improve clinical outcomes, announced today the launch of its national marketing campaign to improve patient outcomes for diabetes, high blood pressure and emphysema.

7 Jun 2004

Crucial discovery may help better diagnose and treat children with Hirschsprung disease

Researchers at Fox Chase Cancer Center have made a crucial discovery that may help physicians better diagnose and treat children with Hirschsprung disease, a debilitating and sometimes life-threatening ailment that causes bowel obstruction and involves an array of genetic changes.

5 Jun 2004

Evidence that abnormally short telomeres play a role in the early development of cancer

Scientists at the Johns Hopkins Kimmel Cancer Center say they have evidence that abnormally short telomeres - the end-caps on chromosomes that normally preserve genetic integrity -appear to play a role in the early development of many types of cancer.

27 May 2004

Genome research sheds light on Bardet-Biedl syndrome

By comparing the genomes of an alga, a weed and humans, a team of researchers has identified a new gene behind Bardet-Biedl syndrome (BBS), a complex condition marked by learning disabilities, vision loss and obesity.

21 May 2004

Researchers identify new genes that control the formation of cilia found throughout the human body

Howard Hughes Medical Institute researchers have used a combination of brainpower and computer power to identify a multitude of new genes that control the formation of tiny, hair-like cilia that stipple the surfaces of many organs in a wide variety of creatures.

14 May 2004

Research uncovers critical pieces of human genome

Researchers have found precisely the same sequences in the genomes of humans, rats, and mice; sequences that are 95 to 99 percent identical to these can be found in the chicken and dog genomes, as well.

6 May 2004

Launch of myDNA.com breast cancer channel

The myDNA.com Breast Cancer Channel integrates multi-cultural, relevant health information related to medications, clinical trials, support groups, leading hospitals, clinics, healthcare providers, and genetic, genomic and gene expression tests.

6 May 2004

IT has the power to transform the pharmaceutical industry

Information technology has the power to transform the pharmaceutical industry, if businesses apply it correctly. That’s the conclusion of Pharma 2010: Silicon Reality, a report from IBM Business Consulting Services (BCS).

5 May 2004

Scientists have unraveled the behavior of one key component of bacteria

The researchers studied a mechanism of action they call the "magic spot" – an important regulator of gene expression. They describe their results in the current issue of the journal Cell.

29 Apr 2004

Latest research on obesity, diabetes, hormone replacement therapy to be presented

From reviewing the latest trends and clinical research in the field of endocrinology to debating the nation's obesity epidemic and the ethnic disparities in health care, the American Association of Clinical Endocrinologists' (AACE) Thirteenth Annual Meeting and Clinical Congress will highlight the current revolution in endocrinology.

29 Apr 2004

Scientists identify six genes associated with the most common form of non-Hodgkin's lymphoma

In a paper that will be published on Thursday, April 29, 2004 in the New England Journal of Medicine, a team of scientists from Stanford University and Applied Biosystems, an Applera Corporation business, describe the identification of six genes associated with survival in diffuse large B cell lymphoma (DLBCL), the most common form of non-Hodgkin's lymphoma.

28 Apr 2004

New analytical approach that combines genetic and clinical data to give individualized prognosis of cancer recurrence

Researchers at Duke University have developed a new analytical approach that combines genetic and clinical data to give cancer patients an individualized prognosis of their cancer recurrence. The information could prove critical in deciding how aggressively to treat the disease following surgery.

26 Apr 2004

Genetic connection between humans, mice and dogs

The discovery that humans are genetically close to mice and dogs might make people develop greater respect for life, J. Craig Venter, a major contributor to the historic mapping of the human genome, said.

16 Apr 2004

New tool for study of carbohydrates could aid drug research

While many dieters are trying to cut carbs, a University of New Hampshire (UNH) biochemist has invented a way to capture them so scientists can more easily study their structure.

13 Apr 2004

Extended lymph node dissection fails to increase survival among gastric cancer patients

Extended lymph node dissection – a treatment for gastric cancer involving the surgical removal of lymph nodes near the tumor, in distant areas of the stomach, and in some cases, in combination with the removal of the spleen and pancreas tail – has shown no long-term survival benefit for gastric cancer patients, according to the largest randomized trial of limited and extended lymph node dissection among this population.